About Publications

Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.


  • Released: September 15, 2008
    Design Considerations for Evaluating the Impact of PEPFAR is the summary of a 2-day workshop on methodological, policy, and practical design considerations for a future evaluation of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) interventions carried out under the President’s Emergency Plan for AIDS Relief (PEPFAR), which was convened by the Institute of Medicine (IOM) on April 30 and May 1, 2007.
  • Released: September 12, 2008
    The National Children s Study (NCS) is planned to be the largest long-term study of environmental and genetic effects on children s health ever conducted in the United States. By archiving all of the data collected, the NCS is intended to provide a valuable resource for analyses conducted many years into the future. This report evaluates the research plan for the NCS, by assessing the scientific rigor of the study and the extent to which it is being carried out with methods, measures, and collection of data and specimens to maximize the scientific yield of the study.
  • Released: September 05, 2008
    The Institute of Medicine (IOM) letter report Review Of ATSDR’s Great Lakes Report Drafts presents the details of an IOM committee’s evaluation of the Agency for Toxic Substances and Disease Registry (ATSDR) unofficial report drafts looking at health and pollution data from the Great Lakes region, of ATSDR’s response to review, as well as of the concerns of the Office of the Director of ATSDR and the Office of the Director of the Coordinating Center for Environmental Health and Injury Prevention (CCEHIP).
  • Released: August 27, 2008
    Traumatic Injury Research at NIOSH is the sixth report in the series Reviews of Research Programs of the National Institute for Occupational Safety and Health.
  • Released: August 22, 2008
    The majority of drugs prescribed for children—50 to 75 percent—have not been tested in pediatric populations. Addressing the Barriers to Pediatric Drug Development is the summary of a workshop that was organized to identify barriers to the development and testing of drugs for pediatric populations, as well as ways in which the system can be improved to facilitate better treatments for children.
  • Released: August 15, 2008
    On March 3-4, 2008, the Institute of Medicine (IOM) Forum on Medical and Public Health Preparedness for Catastrophic Events hosted a workshop titled “Medical Countermeasures Dispensing.” The overall objective was to discuss a range of solutions to rapidly provide medical countermeasures to protect large numbers of people prior to or during a public health emergency, such as a bioterrorist attack or infectious disease outbreak. The United States is currently unprepared to confront the range of threats it is facing, and it must plan aggressively to counteract the threat of these and other future public health emergencies.
  • Released: August 08, 2008
    Growing interest in publicly funded programs for young children has drawn attention to whether and how Head Start and other early childhood programs should be asked to prove their worth. Congress asked the National Research Council for guidance on how to identify important outcomes for children from birth to age 5 and how best to assess them in preschools, child care, and other early childhood programs. The Research Council's new report concludes that well-planned assessments can inform teaching and efforts to improve programs and can contribute to better outcomes for children, but poor assessments or misuse of the results can harm both children and programs. The report offers principles to guide the design, implementation, and use of assessments in early childhood settings.
  • Released: July 30, 2008
    In response to veterans' ongoing concerns and recent publications in the literature, IOM updated its report, Depleted Uranium, Sarin, Pyridostigmine Bromide, and Vaccines. In this most recent report, the committee concluded that there is still not enough evidence to determine whether exposure to depleted uranium is associated with long-term health problems.
  • Released: July 30, 2008
    Depleted uranium, a component of some weapons systems, has been in use by the U.S. military since the 1991 Gulf War. Military personnel have been exposed to depleted uranium as the result of friendly fire incidents, cleanup and salvage operations, and proximity to burning depleted uranium-containing tanks and ammunition. Under a Congressional mandate, the Department of Defense sought guidance from the Institute of Medicine in evaluating the feasibility and design of an epidemiologic study that would assess health outcomes of exposure to depleted uranium.
  • Released: July 10, 2008
    The Bill and Melinda Gates Foundation requested that the Institute of Medicine (IOM) conduct an independent assessment of the IPTi efficacy studies using sulfadoxine-pyrimethamine (IPTi-SP) that have been previously conducted by the IPTi Consortium. The IOM convened a committee to evaluate the evidence concerning IPTi-SP, which included addressing issues related to its utility and safety, as well as program management aspects of IPTi. The resulting letter report contains the findings, conclusions, and recommendations of the IOM committee.
Buy CJC 1295 DAC online in USA

steroid-pharm.com